Home - Products - Others - Other Targets - (S,R,S)-AHPC-C4-NH2 hydrochloride

(S,R,S)-AHPC-C4-NH2 hydrochloride

CAS No. 2245697-83-8

(S,R,S)-AHPC-C4-NH2 hydrochloride( VH032-C4-NH2 hydrochloride | VHL Ligand-Linker Conjugates 13 | E3 ligase Ligand-Linker Conjugates 28 )

Catalog No. M27010 CAS No. 2245697-83-8

(S,R,S)-AHPC-C4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and a linker.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 30 In Stock
10MG 37 In Stock
25MG 61 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (S,R,S)-AHPC-C4-NH2 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    (S,R,S)-AHPC-C4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and a linker.
  • Description
    (S,R,S)-AHPC-C4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating the (S,R,S)-AHPC based VHL ligand and a linker.(In Vitro):PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein.
  • In Vitro
    PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
  • In Vivo
    ——
  • Synonyms
    VH032-C4-NH2 hydrochloride | VHL Ligand-Linker Conjugates 13 | E3 ligase Ligand-Linker Conjugates 28
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    LIN28
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2245697-83-8
  • Formula Weight
    566.16
  • Molecular Formula
    C27H40ClN5O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 109.6 mg/mL (193.58 )
  • SMILES
    O=C(N[C@@H](C(C)(C)C)C(N1C[C@H](O)C[C@H]1C(NCC2=CC=C(C=C2)C3=C(C)N=CS3)=O)=O)CCCCN.[H]Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.VG D’Agostino, et al. Screening Approaches for Targeting Ribonucleoprotein Complexes: A New Dimension for Drug Discovery. Slas Discovery, 2019.
molnova catalog
related products
  • L-JNKI-1

    L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK, it has been shown to effectively inhibit JNK activity in in vivo studies.

  • OD1

    Potent rat Nav1.7, human Nav1.4 and rat Nav1.6 channel activator (EC50 values are 7, 10 and 47 nM, respectively). Exhibits minimal activation at mammalian Nav1.2, Nav1.3 and Nav1.5 (EC50 values >3 μM). Inhibits fast inactivation on all channels. Increases peak currents at all voltages and stimulates a persistent Na+ current at hNav1.7 channel. Increases hyperpolarization at Nav1.4 and Nav1.6 channels. Induces spontaneous pain in vivo.

  • 1H-Purine-2,6-dione

    TH5427 hydrochloride is a potent, selective NUDT5 inhibitor (IC50=29 nM). TH5427 hydrochloride shows an apparent 690-fold selectivity for NUDT5 over MTH1. TH5427 hydrochloride blocks progestin-dependent, PAR-derived nuclear ATP synthesis and subsequent chromatin remodeling, gene regulation and proliferation in breast cancer cells.